27.58 <%= Resources.Global.txtUp %>
Updated 20/08/2019
Change % 0.46% Stock price increasing
Change 0.125 Stock price increasing
Volume 0
High 27.58
Low 27.58
Open 27.58
ISIN JP3546800008
Prev close 27.45
# of shares 759.52M
Market cap 20,944M EUR
Intraday

Market closed
Terumo Corp
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  27.58 -0.2% Stock price decreasing 9.0% Stock price increasing 10.3% Stock price increasing 4.1% Stock price increasing 18.7% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Becton Dickinson and Company 253.37 2.8% Stock price increasing 0.3% Stock price increasing 7.5% Stock price increasing 1.5% Stock price increasing 0.8% Stock price increasing 12.4% Stock price increasing
 
Boston Scientific Corporation 42.55 1.6% Stock price increasing 0.1% Stock price increasing 12.8% Stock price increasing 5.0% Stock price increasing 23.4% Stock price increasing 20.4% Stock price increasing
 
Johnson & Johnson 131.53 0.8% Stock price increasing 2.2% Stock price increasing -5.2% Stock price decreasing -3.7% Stock price decreasing -2.3% Stock price decreasing 1.9% Stock price increasing
 
Fresenius SE+CO.KGAA O.N. 43.90 5.1% Stock price increasing -2.2% Stock price decreasing -8.0% Stock price decreasing -9.9% Stock price decreasing -34.0% Stock price decreasing 3.6% Stock price increasing

Company profile

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Peers

Instruments Last Change  
Becton Dicki.. 253.37 1.6% Stock price increasing
Boston Scien.. 42.55 0.1% Stock price increasing
Johnson & Jo.. 131.53 0.7% Stock price increasing
Fresenius SE.. 43.90 0.9% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 06:51:38
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB4 - 2019-08-22 07:51:38 - 2019-08-22 06:51:38 - 1000 - Website: OKAY